Europe Antibody Drug Conjugate Market Report 2016

November 2016 | 113 pages | ID: EF08EFC77E7EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antibody Drug Conjugate

Revenue, means the sales value of Antibody Drug Conjugate

This report studies sales (consumption) of Antibody Drug Conjugate in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Seattle Genetics/Takeda
• Roche
• ImmunoGen
• Immunomedics
• Pfizer
• Celldex Therapeutics
• Millennium Pharmaceuticals
• Bayer HealthCare
• Mersana Therapeutics
• Heidelberg Pharma
• Oxford BioTherapeutics

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Antibody Drug Conjugate in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Adcetris
• Kadcyla
• Type III

Split by application, this report focuses on sales, market share and growth rate of Antibody Drug Conjugate in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Antibody Drug Conjugate Market Report 2016

1 ANTIBODY DRUG CONJUGATE OVERVIEW

1.1 Product Overview and Scope of Antibody Drug Conjugate
1.2 Classification of Antibody Drug Conjugate
  1.2.1 Adcetris
  1.2.2 Kadcyla
  1.2.3 Type III
1.3 Application of Antibody Drug Conjugate
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Antibody Drug Conjugate Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Antibody Drug Conjugate (2011-2021)
  1.5.1 Europe Antibody Drug Conjugate Sales and Growth Rate (2011-2021)
  1.5.2 Europe Antibody Drug Conjugate Revenue and Growth Rate (2011-2021)

2 EUROPE ANTIBODY DRUG CONJUGATE BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Antibody Drug Conjugate Market Competition by Manufacturers
  2.1.1 Europe Antibody Drug Conjugate Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Antibody Drug Conjugate Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Antibody Drug Conjugate (Volume and Value) by Type
  2.2.1 Europe Antibody Drug Conjugate Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Antibody Drug Conjugate Revenue and Market Share by Type (2011-2016)
2.3 Europe Antibody Drug Conjugate (Volume and Value) by Countries
  2.3.1 Europe Antibody Drug Conjugate Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Antibody Drug Conjugate Revenue and Market Share by Countries (2011-2016)
2.4 Europe Antibody Drug Conjugate (Volume) by Application

3 GERMANY ANTIBODY DRUG CONJUGATE (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Antibody Drug Conjugate Sales and Value (2011-2016)
  3.1.1 Germany Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
  3.1.2 Germany Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Antibody Drug Conjugate Sales Price Trend (2011-2016)
3.2 Germany Antibody Drug Conjugate Sales and Market Share by Manufacturers
3.3 Germany Antibody Drug Conjugate Sales and Market Share by Type
3.4 Germany Antibody Drug Conjugate Sales and Market Share by Application

4 FRANCE ANTIBODY DRUG CONJUGATE (VOLUME, VALUE AND SALES PRICE)

4.1 France Antibody Drug Conjugate Sales and Value (2011-2016)
  4.1.1 France Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
  4.1.2 France Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
  4.1.4 France Antibody Drug Conjugate Sales Price Trend (2011-2016)
4.2 France Antibody Drug Conjugate Sales and Market Share by Manufacturers
4.3 France Antibody Drug Conjugate Sales and Market Share by Type
4.4 France Antibody Drug Conjugate Sales and Market Share by Application

5 UK ANTIBODY DRUG CONJUGATE (VOLUME, VALUE AND SALES PRICE)

5.1 UK Antibody Drug Conjugate Sales and Value (2011-2016)
  5.1.1 UK Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
  5.1.2 UK Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
  5.1.5 UK Antibody Drug Conjugate Sales Price Trend (2011-2016)
5.2 UK Antibody Drug Conjugate Sales and Market Share by Manufacturers
5.3 UK Antibody Drug Conjugate Sales and Market Share by Type
5.4 UK Antibody Drug Conjugate Sales and Market Share by Application

6 RUSSIA ANTIBODY DRUG CONJUGATE (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Antibody Drug Conjugate Sales and Value (2011-2016)
  6.1.1 Russia Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
  6.1.2 Russia Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Antibody Drug Conjugate Sales Price Trend (2011-2016)
6.2 Russia Antibody Drug Conjugate Sales and Market Share by Manufacturers
6.3 Russia Antibody Drug Conjugate Sales and Market Share by Type
6.4 Russia Antibody Drug Conjugate Sales and Market Share by Application

7 ITALY ANTIBODY DRUG CONJUGATE (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Antibody Drug Conjugate Sales and Value (2011-2016)
  7.1.1 Italy Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
  7.1.2 Italy Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Antibody Drug Conjugate Sales Price Trend (2011-2016)
7.2 Italy Antibody Drug Conjugate Sales and Market Share by Manufacturers
7.3 Italy Antibody Drug Conjugate Sales and Market Share by Type
7.4 Italy Antibody Drug Conjugate Sales and Market Share by Application

8 SPAIN ANTIBODY DRUG CONJUGATE (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Antibody Drug Conjugate Sales and Value (2011-2016)
  8.1.1 Spain Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
  8.1.2 Spain Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Antibody Drug Conjugate Sales Price Trend (2011-2016)
8.2 Spain Antibody Drug Conjugate Sales and Market Share by Manufacturers
8.3 Spain Antibody Drug Conjugate Sales and Market Share by Type
8.4 Spain Antibody Drug Conjugate Sales and Market Share by Application

9 BENELUX ANTIBODY DRUG CONJUGATE (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Antibody Drug Conjugate Sales and Value (2011-2016)
  9.1.1 Benelux Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Antibody Drug Conjugate Sales Price Trend (2011-2016)
9.2 Benelux Antibody Drug Conjugate Sales and Market Share by Manufacturers
9.3 Benelux Antibody Drug Conjugate Sales and Market Share by Type
9.4 Benelux Antibody Drug Conjugate Sales and Market Share by Application

10 EUROPE ANTIBODY DRUG CONJUGATE MANUFACTURERS ANALYSIS

10.1 Seattle Genetics/Takeda
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Antibody Drug Conjugate Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Roche
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Antibody Drug Conjugate Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Roche Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 ImmunoGen
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Antibody Drug Conjugate Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Immunomedics
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Antibody Drug Conjugate Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Pfizer
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Antibody Drug Conjugate Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Celldex Therapeutics
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Antibody Drug Conjugate Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Millennium Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Antibody Drug Conjugate Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Bayer HealthCare
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Antibody Drug Conjugate Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Mersana Therapeutics
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Antibody Drug Conjugate Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Heidelberg Pharma
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Antibody Drug Conjugate Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Oxford BioTherapeutics

11 ANTIBODY DRUG CONJUGATE MANUFACTURING COST ANALYSIS

11.1 Antibody Drug Conjugate Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Antibody Drug Conjugate

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Antibody Drug Conjugate Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE ANTIBODY DRUG CONJUGATE MARKET FORECAST (2016-2021)

14.1 Germany Antibody Drug Conjugate Sales Forecast (2016-2021)
14.2 France Antibody Drug Conjugate Sales Forecast (2016-2021)
14.3 UK Antibody Drug Conjugate Sales Forecast (2016-2021)
14.4 Russia Antibody Drug Conjugate Sales Forecast (2016-2021)
14.5 Italy Antibody Drug Conjugate Sales Forecast (2016-2021)
14.6 Spain Antibody Drug Conjugate Sales Forecast (2016-2021)
14.7 Benelux Antibody Drug Conjugate Sales Forecast (2016-2021)
14.8 Europe Antibody Drug Conjugate Sales Forecast by Type (2016-2021)
14.9 Europe Antibody Drug Conjugate Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antibody Drug Conjugate
Table Classification of Antibody Drug Conjugate
Figure Europe Sales Market Share of Antibody Drug Conjugate by Type in 2015
Figure Adcetris Picture
Figure Kadcyla Picture
Table Application of Antibody Drug Conjugate
Figure Europe Sales Market Share of Antibody Drug Conjugate by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Antibody Drug Conjugate Revenue and Growth Rate (2011-2021)
Figure France Antibody Drug Conjugate Revenue and Growth Rate (2011-2021)
Figure UK Antibody Drug Conjugate Revenue and Growth Rate (2011-2021)
Figure Russia Antibody Drug Conjugate Revenue and Growth Rate (2011-2021)
Figure Italy Antibody Drug Conjugate Revenue and Growth Rate (2011-2021)
Figure Spain Antibody Drug Conjugate Revenue and Growth Rate (2011-2021)
Figure Benelux Antibody Drug Conjugate Revenue and Growth Rate (2011-2021)
Figure Europe Antibody Drug Conjugate Sales and Growth Rate (2011-2021)
Figure Europe Antibody Drug Conjugate Revenue and Growth Rate (2011-2021)
Table Europe Antibody Drug Conjugate Sales of Key Manufacturers (2015 and 2016)
Table Europe Antibody Drug Conjugate Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antibody Drug Conjugate Sales Share by Manufacturers
Figure 2016 Antibody Drug Conjugate Sales Share by Manufacturers
Table Europe Antibody Drug Conjugate Revenue by Manufacturers (2015 and 2016)
Table Europe Antibody Drug Conjugate Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Antibody Drug Conjugate Revenue Share by Manufacturers
Table 2016 Europe Antibody Drug Conjugate Revenue Share by Manufacturers
Table Europe Antibody Drug Conjugate Sales and Market Share by Type (2011-2016)
Table Europe Antibody Drug Conjugate Sales Share by Type (2011-2016)
Figure Sales Market Share of Antibody Drug Conjugate by Type (2011-2016)
Figure Europe Antibody Drug Conjugate Sales Growth Rate by Type (2011-2016)
Table Europe Antibody Drug Conjugate Revenue and Market Share by Type (2011-2016)
Table Europe Antibody Drug Conjugate Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antibody Drug Conjugate by Type (2011-2016)
Figure Europe Antibody Drug Conjugate Revenue Growth Rate by Type (2011-2016)
Table Europe Antibody Drug Conjugate Sales and Market Share by Countries (2011-2016)
Table Europe Antibody Drug Conjugate Sales Share by Countries (2011-2016)
Figure Sales Market Share of Antibody Drug Conjugate by Countries (2011-2016)
Table Europe Antibody Drug Conjugate Revenue and Market Share by Countries (2011-2016)
Table Europe Antibody Drug Conjugate Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Antibody Drug Conjugate by Countries (2011-2016)
Table Europe Antibody Drug Conjugate Sales and Market Share by Application (2011-2016)
Table Europe Antibody Drug Conjugate Sales Share by Application (2011-2016)
Figure Sales Market Share of Antibody Drug Conjugate by Application (2011-2016)
Figure Germany Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
Figure Germany Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
Figure Germany Antibody Drug Conjugate Sales Price Trend (2011-2016)
Table Germany Antibody Drug Conjugate Sales by Manufacturers (2015 and 2016)
Table Germany Antibody Drug Conjugate Market Share by Manufacturers (2015 and 2016)
Table Germany Antibody Drug Conjugate Sales by Type (2015 and 2016)
Table Germany Antibody Drug Conjugate Market Share by Type (2015 and 2016)
Table Germany Antibody Drug Conjugate Sales by Application (2015 and 2016)
Table Germany Antibody Drug Conjugate Market Share by Application (2015 and 2016)
Figure France Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
Figure France Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
Figure France Antibody Drug Conjugate Sales Price Trend (2011-2016)
Table France Antibody Drug Conjugate Sales by Manufacturers (2015 and 2016)
Table France Antibody Drug Conjugate Market Share by Manufacturers (2015 and 2016)
Table France Antibody Drug Conjugate Sales by Type (2015 and 2016)
Table France Antibody Drug Conjugate Market Share by Type (2015 and 2016)
Table France Antibody Drug Conjugate Sales by Application (2015 and 2016)
Table France Antibody Drug Conjugate Market Share by Application (2015 and 2016)
Figure UK Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
Figure UK Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
Figure UK Antibody Drug Conjugate Sales Price Trend (2011-2016)
Table UK Antibody Drug Conjugate Sales by Manufacturers (2015 and 2016)
Table UK Antibody Drug Conjugate Market Share by Manufacturers (2015 and 2016)
Table UK Antibody Drug Conjugate Sales by Type (2015 and 2016)
Table UK Antibody Drug Conjugate Market Share by Type (2015 and 2016)
Table UK Antibody Drug Conjugate Sales by Application (2015 and 2016)
Table UK Antibody Drug Conjugate Market Share by Application (2015 and 2016)
Figure Russia Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
Figure Russia Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
Figure Russia Antibody Drug Conjugate Sales Price Trend (2011-2016)
Table Russia Antibody Drug Conjugate Sales by Manufacturers (2015 and 2016)
Table Russia Antibody Drug Conjugate Market Share by Manufacturers (2015 and 2016)
Table Russia Antibody Drug Conjugate Sales by Type (2015 and 2016)
Table Russia Antibody Drug Conjugate Market Share by Type (2015 and 2016)
Table Russia Antibody Drug Conjugate Sales by Application (2015 and 2016)
Table Russia Antibody Drug Conjugate Market Share by Application (2015 and 2016)
Figure Italy Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
Figure Italy Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
Figure Italy Antibody Drug Conjugate Sales Price Trend (2011-2016)
Table Italy Antibody Drug Conjugate Sales by Manufacturers (2015 and 2016)
Table Italy Antibody Drug Conjugate Market Share by Manufacturers (2015 and 2016)
Table Italy Antibody Drug Conjugate Sales by Type (2015 and 2016)
Table Italy Antibody Drug Conjugate Market Share by Type (2015 and 2016)
Table Italy Antibody Drug Conjugate Sales by Application (2015 and 2016)
Table Italy Antibody Drug Conjugate Market Share by Application (2015 and 2016)
Figure Spain Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
Figure Spain Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
Figure Spain Antibody Drug Conjugate Sales Price Trend (2011-2016)
Table Spain Antibody Drug Conjugate Sales by Manufacturers (2015 and 2016)
Table Spain Antibody Drug Conjugate Market Share by Manufacturers (2015 and 2016)
Table Spain Antibody Drug Conjugate Sales by Type (2015 and 2016)
Table Spain Antibody Drug Conjugate Market Share by Type (2015 and 2016)
Table Spain Antibody Drug Conjugate Sales by Application (2015 and 2016)
Table Spain Antibody Drug Conjugate Market Share by Application (2015 and 2016)
Figure Benelux Antibody Drug Conjugate Sales and Growth Rate (2011-2016)
Figure Benelux Antibody Drug Conjugate Revenue and Growth Rate (2011-2016)
Figure Benelux Antibody Drug Conjugate Sales Price Trend (2011-2016)
Table Benelux Antibody Drug Conjugate Sales by Manufacturers (2015 and 2016)
Table Benelux Antibody Drug Conjugate Market Share by Manufacturers (2015 and 2016)
Table Benelux Antibody Drug Conjugate Sales by Type (2015 and 2016)
Table Benelux Antibody Drug Conjugate Market Share by Type (2015 and 2016)
Table Benelux Antibody Drug Conjugate Sales by Application (2015 and 2016)
Table Benelux Antibody Drug Conjugate Market Share by Application (2015 and 2016)
Table Antibody Drug Conjugate Basic Information List
Table Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Antibody Drug Conjugate Sales Market Share (2011-2016)
Table ImmunoGen Basic Information List
Table ImmunoGen Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table ImmunoGen Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Immunomedics Basic Information List
Table Immunomedics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunomedics Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celldex Therapeutics Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Millennium Pharmaceuticals Basic Information List
Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Mersana Therapeutics Basic Information List
Table Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mersana Therapeutics Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Heidelberg Pharma Basic Information List
Table Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heidelberg Pharma Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Oxford BioTherapeutics Basic Information List
Table Oxford BioTherapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oxford BioTherapeutics Antibody Drug Conjugate Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugate
Figure Manufacturing Process Analysis of Antibody Drug Conjugate
Figure Antibody Drug Conjugate Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2015
Table Major Buyers of Antibody Drug Conjugate
Table Distributors/Traders List
Figure Germany Antibody Drug Conjugate Sales and Growth Rate Forecast (2016-2021)
Figure Germany Antibody Drug Conjugate Revenue and Growth Rate Forecast (2016-2021)
Figure France Antibody Drug Conjugate Sales and Growth Rate Forecast (2016-2021)
Figure France Antibody Drug Conjugate Revenue and Growth Rate Forecast (2016-2021)
Figure UK Antibody Drug Conjugate Sales and Growth Rate Forecast (2016-2021)
Figure UK Antibody Drug Conjugate Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Antibody Drug Conjugate Sales and Growth Rate Forecast (2016-2021)
Figure Russia Antibody Drug Conjugate Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Antibody Drug Conjugate Sales and Growth Rate Forecast (2016-2021)
Figure Italy Antibody Drug Conjugate Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Antibody Drug Conjugate Sales and Growth Rate Forecast (2016-2021)
Figure Spain Antibody Drug Conjugate Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Antibody Drug Conjugate Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Antibody Drug Conjugate Revenue and Growth Rate Forecast (2016-2021)
Table Europe Antibody Drug Conjugate Sales Forecast by Type (2016-2021)
Table Europe Antibody Drug Conjugate Sales Forecast by Application (2016-2021)